Time-invariant system

Shareholder Lawsuit Charges Meta Platforms with Prioritizing Profits over Shareholders

Retrieved on: 
Tuesday, October 4, 2022

A class action was filed today in the Delaware Court of Chancery against the directors of Meta Platforms, Inc. by James McRitchie, an advocate for shareholders rights, who often works with The Shareholder Commons , a non-profit advocate for diversified shareholders.

Key Points: 
  • A class action was filed today in the Delaware Court of Chancery against the directors of Meta Platforms, Inc. by James McRitchie, an advocate for shareholders rights, who often works with The Shareholder Commons , a non-profit advocate for diversified shareholders.
  • The lawsuit outlines numerous reports that have highlighted Metas prioritization of profits over the interests of communities around the world, including its users.
  • This lawsuit only comes after Metas board decided not to investigate how the reported behavior harms the economy that underpins the investment portfolios of its own shareholders.
  • The Shareholder Commons (TSC) is a non-profit organization that addresses social and environmental issues from the perspective of shareholders who diversify their investments to optimize risk and return.

Recommendation Engine Market Analysis Report 2022-2028 Featuring IBM, SAP, Salesforce, HPE, Oracle, Google, Microsoft, Intel, AWS, and Sentient Technologies - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 4, 2022

The latest report on Recommendation Engine Market understands market size estimates, forecasts, market shares, competition analysis, along with industry trends of Recommendation Engine with emphasis on market timelines and technology roadmaps analysis.

Key Points: 
  • The latest report on Recommendation Engine Market understands market size estimates, forecasts, market shares, competition analysis, along with industry trends of Recommendation Engine with emphasis on market timelines and technology roadmaps analysis.
  • The Recommendation Engine market is segmented by Technology, Application, Type, Deployment Mode, End-user, Region.
  • Analysis of the global market with a special focus on high growth application in each vertical and fast-growing market segments.
  • The report also covers qualitative analysis of the market, by incorporating complete pricing and cost analysis of components & products, Porter's analysis and PEST (Political, Economic, Social & Technological factor) analysis of the market.

Elicio Therapeutics Announces Publication of Preclinical Data in Science Translational Medicine Demonstrating the AMP Platform Promotes Uptake of Intranasal Vaccine in the Mucosa Amplifying Immune Response

Retrieved on: 
Tuesday, October 4, 2022

BOSTON, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Elicio Therapeutics, a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases, today announced the publication of preclinical data from the research laboratory of Dr. Darrell Irvine at the Massachusetts Institute of Technology (MIT), demonstrating Elicio’s Amphiphile (AMP) platform conjugated to protein antigens promotes uptake in the nasal mucosa and amplifies immune responses after intranasal immunization. Immunization through airway surfaces has proven challenging due to poor vaccine uptake across these linings. The data presented here represents a promising strategy to promote mucosal immunity against HIV, SARS-CoV-2, and other infectious diseases. The data was published in Science Translational Medicine and can be accessed here.

Key Points: 
  • The data was published in Science Translational Medicine and can be accessed here .
  • Delivery of vaccine components across mucosal barriers has been a major challenge for mucosal vaccine development.
  • This data demonstrates that AMP-modification can improve vaccine uptake across the nasal mucosa via interactions with albumin and the neonatal Fc receptor known as the mucosal gateway.
  • The findings are encouraging for the translational potential of this approach to induce antibodies in a variety of mucosal sites after intranasal immunization.

Global Typhoid Fever Vaccines Market Report 2022: Increasing Government & NGO Initiatives to Raise Awareness Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 4, 2022

The "Typhoid Fever Vaccines Market, by Vaccine Type, by Route of Administration, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Typhoid Fever Vaccines Market, by Vaccine Type, by Route of Administration, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • Typhoid fever is a bacterial infection caused by Salmonella typhi, which causes symptoms such as prolonged fever, headache, nausea, loss of appetite, and constipation or sometimes diarrhea.
  • Typhoid fever vaccines are the biological formulations, which provide immunity and protect an individual against typhoid fever.
  • Increasing initiatives by governments and various other organizations to increase awareness about typhoid vaccine and rising access of new vaccines is expected to drive the typhoid fever vaccines market growth during forecast period.

Radiology Information Systems Market Worth $1.9 Billion By 2030: Grand View Research, Inc.

Retrieved on: 
Monday, October 3, 2022

North America led the radiology information systems market in 2021 in terms of revenue attributed to the technological advancements and presence of major market players.

Key Points: 
  • North America led the radiology information systems market in 2021 in terms of revenue attributed to the technological advancements and presence of major market players.
  • Read 100 page market research report, " Radiology Information Systems Market Size, Share & Trends Analysis Report By Product, By Deployment Mode (Web-based, On-premise, Cloud-based), By End Use, By Region, And Segment Forecasts, 2022 - 2030 ", published by Grand View Research.
  • The integration of Artificial Intelligence (AI) into radiology information system (RIS) offers lucrative growth opportunities for the market.
  • Grand View Research has segmented the global radiology information systems market based on the deployment mode, product, and end-use.

Radiology Information Systems Market Worth $1.9 Billion By 2030: Grand View Research, Inc.

Retrieved on: 
Monday, October 3, 2022

North America led the radiology information systems market in 2021 in terms of revenue attributed to the technological advancements and presence of major market players.

Key Points: 
  • North America led the radiology information systems market in 2021 in terms of revenue attributed to the technological advancements and presence of major market players.
  • Read 100 page market research report, " Radiology Information Systems Market Size, Share & Trends Analysis Report By Product, By Deployment Mode (Web-based, On-premise, Cloud-based), By End Use, By Region, And Segment Forecasts, 2022 - 2030 ", published by Grand View Research.
  • The integration of Artificial Intelligence (AI) into radiology information system (RIS) offers lucrative growth opportunities for the market.
  • Grand View Research has segmented the global radiology information systems market based on the deployment mode, product, and end-use.

Over Half of Medical Providers Say Medication Shortage is Most Common Struggle of Supply Chain Crisis

Retrieved on: 
Monday, October 3, 2022

To get a pulse on current supply chain struggles and how to address them, Software Advice surveyed healthcare providers who have experienced this crisis firsthand.

Key Points: 
  • To get a pulse on current supply chain struggles and how to address them, Software Advice surveyed healthcare providers who have experienced this crisis firsthand.
  • Most providers say their patients have been directly impacted, with the most common consequence being disruption of patient access to prescribed medication.
  • Inventory management platforms that include features for vendors, ordering, and reporting can help practices better tackle the supply chain crisis.
  • View the full report here to learn how providers can address the supply chain crisis.

PENELOPE and the Beauty Bar's MEDISPA Division Celebrates First Anniversary, Introduces New MediSpa Treatments

Retrieved on: 
Monday, October 3, 2022

Seattle's PENELOPE and the Beauty Bar Celebrates First Anniversary of MediSpa Division, Introduces New MediSpa Treatments

Key Points: 
  • Seattle's PENELOPE and the Beauty Bar Celebrates First Anniversary of MediSpa Division, Introduces New MediSpa Treatments
    Three new MediSpa treatments are being added to the current menu this fall.
  • RF toning, which utilizes Electrical Muscle Stimulation (EMS) which helps refine, restore, and improve the look and strength of muscles in the abdomen.
  • PENELOPE and the Beauty Bar is located in the historic Fairmont Olympic Hotel at 411 University Street, Seattle, WA 98101.
  • For more information on PENELOPE and the Beauty Bar and PENELOPE MEDISPA, please visit www.penelopeandthebeautybar.com .

Recce Pharmaceuticals Announces Expansion and Acceleration of Clinical Programs

Retrieved on: 
Monday, October 3, 2022

SYDNEY Australia, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) (the Company), the Company developing new classes of synthetic anti-infectives, is pleased to provide an updated timeline on its clinical programs with several significant data read-outs in 2022 and 2023.

Key Points: 
  • We have therefore established an ambitious development plan, aiming to get new anti-infective therapies into market as expediently possible.
  • Recces anti-infective pipeline is unique and comprised of broad-spectrum synthetic polymer antibiotics RECCE 327, RECCE 435, and RECCE 529 for viral infections with unique mechanisms of action against hyper-mutation on bacteria and viruses, respectively.
  • Recce wholly owns its automated manufacturing, ready to support first-in-human clinical trials.
  • Recces anti-infective pipeline seeks to exploit the unique capabilities of RECCE technologies targeting synergistic, unmet medical needs.

Qurate Retail Group Names Scott Barnhart Chief Operating Officer

Retrieved on: 
Friday, September 30, 2022

WEST CHESTER, Pa., Sept. 30, 2022 /PRNewswire/ -- Qurate Retail GroupSM, a world leader in video commerce ("vCommerce") across linear TV, ecommerce sites, digital streaming and social platforms, today announced that Scott Barnhart has been appointed Chief Operating Officer (COO), effective immediately. As COO, Barnhart leads Supply Chain, Procurement, Global Business Services, and Corporate Real Estate and Workplace Services (CREWS) for all Qurate Retail Group brands globally; Customer Service and Experience for all U.S. brands; and QVC® and HSN®'s U.S. Fulfillment Operations. Barnhart also oversees the Transformation Management Office for Project Athens, Qurate Retail Group's three-year plan to establish revenue stability, OIBDA margin expansion and incremental cash flow generation. Barnhart reports to David L. Rawlinson II, President and CEO of Qurate Retail, Inc. Qurate Retail Group is part of Qurate Retail, Inc. (Nasdaq: QRTEA, QRTEB, QRTEP), a Fortune 500 company. 

Key Points: 
  • Barnhart reports to David L. Rawlinson II, President and CEO of Qurate Retail, Inc. Qurate Retail Group is part of Qurate Retail, Inc. (Nasdaq:QRTEA, QRTEB, QRTEP), a Fortune 500 company.
  • Barnhart brings Qurate Retail Group 30+ years of international business leadership experience in global supply chain and customer service at multiple Fortune 500 brands and similarly sized global corporations.
  • Qurate Retail Group combines shopping and entertainment to curate products, experiences, conversations and communities for millions of highly discerning shoppers.
  • Qurate Retail, Inc. (NASDAQ: QRTEA, QRTEB, QRTEP) is a Fortune 500 company that includes the Qurate Retail Group portfolio of brands as well as other minority interests and green energy investments.